DCTH

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Delcath Systems (DCTH - Research Report), with a price target of $19.00. The company's shares closed yesterday at $2.80.According to TipRanks, Ramakanth is an analyst with an average return of -14.7% and a 28.76% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as ImmunoGen, MiMedx Group, and Ocugen.Delcath Systems has an analyst consensus of Moderate Buy, with a price target consensus of $19.00, which is a 578.57% upside from current levels. In a report released on November 8, BTIG also reiterated a Buy rating on the stock with a $19.00 price target.
https://www.tipranks.com/news/blurbs/delcath-systems-dcth-receives-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral